Oracle (NYSE: ORCL) Faces China Chip Rule At The Worst Possible Moment For Its Balance Sheet
Oracle (NYSE: ORCL) swung from $11.8 billion in positive free cash flow in fiscal 2024 to negative $23.7 billion in fiscal 2026, leaving it with little room for disruption. That financial fragility is now colliding with a Washington policy move that threatens a meaningful slice of the company’s Asian data…